Public Health

Population health, policy and the data behind prevention.

MHRA expands medicine product information and additional monitoring list

MHRA guidance explains how to find SPCs, PILs and PARs, while detailing the UK additional monitoring list and black triangle reporting.

MHRA’s medicines licensing collection outlines UK routes for approval, variation, safety reporting, advertising, and product information.

A 2026 review examines Lactiplantibacillus plantarum as a biosafe microbial candidate for remediation, agriculture, and One Health applications.

WHO has revised its oral health STEPS module to improve population surveillance, policy-relevant data collection, and routine NCD…

WHO, IOM and IFRC urged countries to build pandemic preparedness that includes migrants, refugees and displaced people across…

WHO’s first global obesity guidelines for children and adolescents recommend lifestyle-based care, selective medicines for teens, and long-term…

A Delphi expert process proposes a hybrid governance framework to reduce misuse risks from synthetic biology, AI, and…

A narrative review examines how physical activity, digital habits, and online exercise interventions intersect with youth mental health…

The Trump administration delayed a rule affecting prescription drug shipments from licensed international pharmacies, raising access concerns and…

Califf, Gottlieb, and Sharpless criticized current HHS leadership at STAT Summit, putting FDA stability and biotech policy back…

Public Health

Population health, policy and the data behind prevention.

In Brief The 5-minute rounds